C12N 9/0042
Nadph-cytochrome p450 reductase
Official title: {NADPH-cytochrome P450 reductase (1.6.2.4)}
C12N9/0042 (Nadph-cytochrome p450 reductase) appears on 145 US grants and 223 published applications in this corpus.
Search patents in C12N- Granted patents
- 145
- Published applications
- 223
- Assignees
- 107
- Inventors
- 463
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 1 |
| 2002 | 1 | 1 |
| 2003 | 4 | 12 |
| 2004 | 1 | 4 |
| 2005 | 1 | 3 |
| 2006 | 6 | 3 |
| 2007 | 0 | 1 |
| 2008 | 1 | 3 |
| 2009 | 1 | 3 |
| 2010 | 1 | 4 |
| 2011 | 1 | 2 |
| 2012 | 2 | 5 |
| 2013 | 1 | 2 |
| 2014 | 4 | 7 |
| 2015 | 5 | 11 |
| 2016 | 9 | 12 |
| 2017 | 9 | 15 |
| 2018 | 12 | 14 |
| 2019 | 8 | 16 |
| 2020 | 9 | 12 |
| 2021 | 13 | 15 |
| 2022 | 10 | 23 |
| 2023 | 8 | 12 |
| 2024 | 9 | 17 |
| 2025 | 13 | 16 |
| 2026 | 6 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Microorganisms for diterpene production23 Jun 2026US 12,662,680 B2Cargill, Incorporated
- Isolation of steviol glycosides16 Jun 2026US 12,655,168 B2Dsm IP Assets B.V.
- Processes for the production of tryptamines7 Apr 2026US 12,595,497 B2Compass Pathfinder Limited
- Improved isolation of steviol glycosides1 Oct 2026US 2026/0297119 A1Dsm IP Assets B.V.
- Recombinant polypeptides for biosynthesis of thymohydroquinone (thq)10 Sep 2026US 2026/0265705 A1Epimeron USA, Inc.
- Abc transporters for the high efficiency production of rebaudiosides3 Sep 2026US 2026/0258467 A1Amyris, Inc.
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Test system comprising stably cyp-transfected or transduced mammalian cells6 Aug 2026US 2026/0226427 A1Brandenburgische Technische Universität Cottbus-Senftenberg
Most cited
By later US patents
- Production of steviol glycosides in microorganisms48US 9,562,251 B2Evolva SA · 2017
- Cloning of cytochrome P450 genes from Nicotiana41US 8,058,504 B2U.S. Smokeless Tobacco Company LLC · 2011
- Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy34US 6,207,648 B1Trustees of Boston University · 2001
- Microbial production of natural sweeteners, diterpenoid steviol glycosides26US 9,284,570 B2Massachusetts Institute of Technology · 2016
- Bioproduction of para-hydroxycinnamic acid24US 6,368,837 B1E. I. du Pont Nemours and Company · 2002